AVDL
Avadel Pharmaceuticals
AVDL
AVDL
80 hedge funds and large institutions have $200M invested in Avadel Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.09% less ownership
Funds ownership: 56% → 55.91% (-0.09%)
32% less capital invested
Capital invested by funds: $294M → $200M (-$93.9M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
80
Holding in Top 10
1
Calls
$6.67M
Puts
$1.63M
Top Buyers
| 1 | +$3.29M | |
| 2 | +$2.06M | |
| 3 | +$1.56M | |
| 4 |
TLP
Tri Locum Partners
New York
|
+$1.03M |
| 5 |
Morgan Stanley
New York
|
+$1.02M |
Top Sellers
| 1 | -$3.59M | |
| 2 | -$3.25M | |
| 3 | -$2.1M | |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$1.06M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$902K |